Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKBA Cream in Papulopustular Rosacea Phase IIa Trial
CTR20260212Phase 2Active
- Sponsor
- Bochuangyuan Biopharmaceutical
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid in papulopustular rosacea, sponsored by Bochuangyuan Biopharmaceutical. Started Feb 2026; status: active.
02
Drugs
3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on CTR20260212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260212.